Jackson Hole Capital Partners, LLC Cassava Sciences Inc Transaction History
Jackson Hole Capital Partners, LLC
- $490 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding SAVA
# of Institutions
173Shares Held
15.8MCall Options Held
3.39MPut Options Held
7.94M-
Black Rock Inc. New York, NY3.22MShares$5.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$3.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.03MShares$1.64 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$1.59 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY790KShares$1.26 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $64.2M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...